Layn Natural Ingredients Acquires $1.5 Million in Ispire's Initial Public Offering

Market by Shenzhen Stock Exchange; Rui Tian
Apr.11.2023
CBD manufacturer Ispire is listed on the NASDAQ stock exchange in the US, with an issue price of $7.00. Layn Natural Ingredients purchased 214,285 shares of Ispire's public offering using its own funds, totaling $1.5 million.

On April 4th, CBD manufacturer Ispire went public on the NASDAQ stock exchange in the United States, issuing 2.7 million common shares at a price of $7.00 per share.

 

Layn Natural Ingredients is a domestic plant extraction industry enterprise mainly engaged in the research, production, and sales of plant standardization extraction and high-purity active monomers.

 

Nebulization products are an important downstream application field of industrial cannabis. According to Frost Sullivan's research data, from 2018 to 2022, the global market size of electronic nebulization devices has an annual growth rate of 18.1%, and it is expected to maintain a growth rate of around 18.5% from 2022 to 2027.

 

Layn Natural Ingredients obtained Ispire's first public offering shares allocation with its own funds

 

On April 7th, Layn Natural Ingredients announced that it used its own funds of $1,499,995 to obtain an allocation of 214,285 shares of Ispire (stock abbreviation "ISPR") in its first public offering on the NASDAQ at a price of $7.00 per share. The shares offered in this IPO were listed on the NASDAQ on April 4, 2023 (local time in the United States).

 

It is beneficial for cooperation in the cannabis field

 

Layn Natural Ingredients stated that its participation in Ispire's IPO strategic placement is to promote deeper cooperation between the two parties in the industrial cannabis business, combining their respective sales channels and other resources to achieve win-win cooperation.

Ispire closed at $7.55 on the first day of its listing, an increase of 7.86%, with a market value of $400 million. As of now, the latest stock price is $7.00, and the latest market value is $368.7 million.

 

Also read:

[1] CBD manufacturer Ispire completes its first public offering, raising $18.9 million

[2] CBD manufacturer Ispire announces the pricing of its first public offering: $7 per share, issuing 2.7 million shares

 

Reference:

[1] Layn Natural Ingredients: Announcement on Obtaining Ispire's First Public Offering Shares Allocation and Listing

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
ATF Cancels Webloc Contract, Raising Questions Over Commercial Location Data in Enforcement
ATF Cancels Webloc Contract, Raising Questions Over Commercial Location Data in Enforcement
The U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has stopped using Webloc, a commercial phone-tracking tool, after lawmakers, a prosecutor and a judge raised legal and privacy concerns over warrantless use of ad-tech location data, a development that may affect data-use boundaries in U.S. enforcement against illicit tobacco, nicotine products and cross-border distribution networks.
Jun.29
FDA 2025 NYTS: Youth E-Cigarette Use Declines but Unauthorized Disposables Remain Prominent; Nicotine Pouch Use Stays Low
FDA 2025 NYTS: Youth E-Cigarette Use Declines but Unauthorized Disposables Remain Prominent; Nicotine Pouch Use Stays Low
The U.S. Food and Drug Administration (FDA) released its 2025 National Youth Tobacco Survey analysis, saying about 2.01 million U.S. middle and high school students currently used any tobacco product; among current youth e-cigarette users, unauthorized disposable brands including Geek Bar, Elf Bar, Lost Mary and Raz had high reported shares, potentially making them a focus for future enforcement.
Jun.24
FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
FDA Sued Over Allowing Some Unauthorized Vapes and Nicotine Pouches to Stay on Market
Public health groups, pediatricians and parents sued the U.S. Food and Drug Administration on July 14, 2026, challenging a May enforcement guidance that they say allows unauthorized e-cigarettes and nicotine pouches to remain on the market while applications are under review.
Jul.15